Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
Authors
Keywords
-
Journal
Cancers
Volume 8, Issue 3, Pages 26
Publisher
MDPI AG
Online
2016-02-25
DOI
10.3390/cancers8030026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast Cancer Risks and Risk Prediction Models
- (2015) Christoph Engel et al. Breast Care
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- Promoter Methylation Status of Ras-Association Domain Family Member in Pheochromocytoma
- (2015) Antje M. Richter et al. Frontiers in Endocrinology
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- RASSF10 is an epigenetically silenced tumor suppressor in gastric cancer
- (2014) ZHENHUA LI et al. ONCOLOGY REPORTS
- RASSF10 is epigenetically silenced and functions as a tumor suppressor in gastric cancer
- (2013) Ziran Wei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma
- (2013) Antje Richter et al. Cancers
- The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer
- (2012) A M Richter et al. Oncogenesis
- RASSF10 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin but Uncommon in Nevus Cell Nevi
- (2011) Peter Helmbold et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer
- (2010) E. M. Wong et al. Cancer Prevention Research
- Frequent epigenetic inactivation of RASSF10 in thyroid cancer
- (2010) Undraga Schagdarsurengin et al. Epigenetics
- Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis
- (2010) V K Hill et al. ONCOGENE
- The N-terminal RASSF family: a new group of Ras-association-domaincontaining proteins, with emerging links to cancer formation
- (2009) Victoria Sherwood et al. BIOCHEMICAL JOURNAL
- The RASSF proteins in cancer; from epigenetic silencing to functional characterization
- (2009) Antje M. Richter et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review
- (2009) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
- The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
- (2009) Luke B Hesson et al. Molecular Cancer
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started